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Abstract
Staphylococci are normally harmless commensals occurring on the skin, mucous mem-
brane and the general environment. However, they are increasingly implicated in dif-
ferent infectious states. Of particular interest is the advent of methicillin-resistant 
Staphylococcus aureus (MRSA) with its attendance resistance to beta lactam antibiotics. 
Several infectious states are now emerging with staphylococci being implicated in the 
infections, e.g. S. saprophyticus has been implicated in urogenital infection. It would be 
interesting to document the prevalence of staphylococci in different infectious state. The 
identification of staphylococci is supposed to be a straightforward procedure, but an 
alarming misidentification rate is emerging in low resource laboratories, especially in 
places where identification is solely by growth and fermentation on mannitol salt agar 
(MSA). Finally, empirical treatment of any staphylococci infection will depend on local 
suspectibility pattern of the strains as the susceptibilities vary from environment to envi-
ronment. This chapter summarizes the current knowledge regarding the prevalence, 
diagnosis and local susceptibility of staphylococci in different parts of the world.
Keywords: misdiagnosis, prevalence, susceptibility, staphylococci, antibiotics, 
identification
1. Introduction
Staphylococci have long history and association with mankind. From their presence in amni-
otic fluid, all through to adulthood, they were once regarded as harmless commensals with 
beneficial effects, e.g. by competing with pathogenic bacteria, but they are now implicated 
in life-threatening infections. Coagulase-negative staphylococci (CoNS) cause invasive infec-
tions in some vulnerable groups of patients, e.g. immunocompromised patients, preterm 
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neonates and people with indwelling medical devices [1]. Staphylococcus epidermidis is 
observed in 33% of blood samples collected from neonates, and it is the second most preva-
lent species observed in orthopedic device-related infections [2, 3]. S. aureus and S. epider-
midis were ranked first in opportunistic infections and the major causative agent of medical 
implants and nosocomial infections in developing countries [4]. S. epidermidis was the com-
monest infectious species followed by S. saprophyticus and S. haemolyticus in a clinical study 
[5]. S. lugdunensis is implicated in infectious endocarditis. Although CoNS possess lesser 
virulence properties than S. aureus, they are more challenging due to their large proportion 
of methicillin-resistant strains with increasing numbers of isolates resistant to glycopep-
tides [6].
Most S. aureus infections used to be in the healthcare setting, but they are now established 
as a causative agent of serious infections in the community [7]. Immunocompromised indi-
viduals are at higher risk of general S. aureus infections (particularly invasive infection, e.g., 
bacteremia) than immunocompetent individuals. The emergence of community-acquired 
methicillin-resistant S. aureus (CA-MRSA) has led to an increase in the severity of infections 
of CA-MRSA in the last two decades [8]. Also, prevalence of methicillin-resistant coagulase-
negative staphylococci has been reported, e.g. prevalence of nasal and pharyngeal carriage 
of methicillin-resistant S. scuri among 195 inpatients and healthcare workers in an healthcare 
center in Serbia has been reported as high in hospitals and possible dissemination across 
hospital wards can occur [9]. Several factors are responsible for transmission of S. aureus infec-
tions, e.g. domesticated animals in household transmission [7], neonates and breastfeeding 
mothers, immunocompromised patients, use of an indwelling intravascular plastic catheter, 
surgical incisions, open wounds, or burns.
The main aim of this chapter therefore is to highlight the current knowledge on prevalence, 
diagnosis and local susceptibility of staphylococci in different parts of the world.
2. Prevalence of staphylococci infections
S. aureus causes many infections including skin, soft tissue and invasive infections (compli-
cated pneumonia, bacteremia, musculoskeletal infections and endocarditis). The common 
staphylococci infections are otitis media, bacteremia, skin infections, pneumonia, endocardi-
tis, neonatal infections, osteomyelitis, food poisoning, toxic shock syndrome and scalded skin 
syndrome. However, there are increasing reports of staphylococcal infections in other parts of 
the body and vulnerable population.
2.1. Prevalence of staphylococci in different diseased condition
There are emerging facts on the role of staphylococci in central nervous system infections. 
In a multinational study performed with 2583 patients in 37 referral centers in 20 coun-
tries to understand the burden of community-acquired central nervous system infections 
between 2012 and 2014 [10], staphylococci and Listeria were responsible for frequent infec-
tions in immunocompromised patients. In another study of 102 patients on maintenance 
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hemodialysis, of 1402 patients hospitalized for infectious spondylodiscitis over a 13-year 
period, MRSA was the commonest pathogen found in the infectious sites followed by coagu-
lase-negative staphylococci [11].
The role of staphylococci in burns and skin infections is well documented. In a retrospective 
study of 123 patients hospitalized in the burn center of Marrakech over a period of 3 years 
(2013–2016), there were 103 infections per 1000 days of treatment in different infective sites 
(blood (18%), skin (69%), lungs (1%) and urinary tract (12%)) with the main infectious organ-
isms being: Staphylococcus sp. (37.7%) and MRSA in 22% of cases [12]. In Japan, a recent study 
investigated the antimicrobial resistance in pathogens isolated from skin and soft-tissue infec-
tions (SSTI) at 40 dermatology departments and clinics resulting in isolation of three main 
organisms (579 of S. aureus 141 (MRSA 24.4%), 240 of coagulase-negative staphylococci and 
41 of Streptococcus pyogenes) identified from 860 strains [13].
Staphylococci are frequently implicated in hospital-acquired bacteremia especially those 
associated with intravascular catheters and staphylococcal bacteremia and they are important 
cause of morbidity. A study that described the epidemiology of healthcare-associated blood-
stream infections for 71,039 patients in 338 Polish hospitals between 2012 and 2015 found 
that the most frequently isolated microorganisms were staphylococci (45.6%) and most of 
them were coagulase-negative (64.4%) and usually caused catheter-related infections. Of 53 S. 
aureus isolated, 24.5% were methicillin-resistant [14].
Immunocompromised patients are at higher risk of staphylococcal infections. In a study over 
a period of 1 year of S. aureus colonization, 81% of adults with human immunodeficiency 
virus (HIV) have higher rates of colonization than the general population [15]. Children with 
immunocompromising conditions are very vulnerable to S. aureus infections with the higher 
risk of development of complications in children with malignancy and high rates of resistance 
to antimicrobials [16].
Staphylococci are frequently implicated in neonatal infections usually within 6 week after 
birth with diseased conditions such as skin lesions, pneumonia, bacteremia, meningitis. In an 
epidemiology study of neonatal infection from 2005 to 2014 in 30 UK neonatal units, E. coli 
(15%), S. aureus (14%) and CoNS were prominent causes of late-onset sepsis in the neonates 
[17]. In sub-Saharan Africa, there is limited information on large-scale study on prevalence of 
staphylococci infections. However, Seale et al. [18] reported that from all neonatal admissions 
in a local hospital in Kenya from 1998 to 2013 to determine CoNS in neonates, CoNS was 
isolated from blood culture in 995 of 9552 (10%) neonates and the neonates with CoNS have 
higher risk of convulsions. Staphylococci were the most prevalent organism in a hospital-
based case–control study in the Regional Hospital, Cameroon between September 2015 and 
August 2016 [19].
Otitis media is an inflammation of middle ear which may lead to hearing loss. Streptococcus 
pneumoniae, Moraxella catarrhalis, Haemophilus influenzae and S. aureus are some of the organ-
isms implicated in acute otitis media. To assess the frequency of bacterial agents in 185 chronic 
suppurative otitis media, Staphylococci spp. (64.9%) were the most prevalent bacteria observed 
[20]. In some developing countries, otitis media may prevail as a result of illiteracy, poverty 
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and poor hygiene. In a study of 263 pus samples from 240 patients in a developing country, 
highest incidence of otitis media was observed in 1–10 year age group with the commonest 
bacteria isolated being S. aureus (36.11%) and CoNS (8.08%) [21].
2.2. MRSA prevalence in Africa
There is variable information on prevalence of MRSA in Africa. The prevalence was lower 
than 50% in most African countries and higher prevalence since 2000 has been observed 
in many African countries (except South Africa). In South Africa, the prevalence decreased 
between 2006 and 2011, while it varied between 23 and 44% for 2000–2007 in Botswana. It 
increased from 16 to 41% between 2002 and 2007 in Tunisia; in Libya, MRSA prevalence was 
31% in 2007, while in Egypt and Algeria the prevalence was 45 and 52% between 2003 and 
2005, respectively, while northern Nigerian had higher MRSA prevalence than the southern 
part with 55 and 39% prevalence in Ethiopia and Ivory Coast, respectively [22].
In a review of 34 reports from 15 countries in Africa, CC5 is the predominant clonal complex in 
healthcare setting in Africa. Hospital-associated MRSA was identified in nine African countries 
with limited spread of European ST80-IV clone to Algeria, Egypt and Tunisia and lack of dis-
tinct difference between MRSA responsible for hospital and community infections. However, 
the community clones (ST8-IV and ST88-IV) were observed in the hospital and community set-
tings in Madagascar, Angola, Príncipe, Cameroon, Ghana, Gabon, Nigeria and São Tomé [23].
The overall prevalence of MRSA was 22.6% from 142 S. aureus isolates obtained from 261 
samples sourced from university staff, students and fomites in Awka, Nigeria with the car-
riage rate being higher in females than male and highest in individuals of 20–30 years [24]. In 
a neonatal septicemia study involving 202 infants with risk factors for clinical features of sep-
ticemia in the first 3 days of life, 12.5% culture were positive with the predominant organisms 
being S. aureus (52%) and 30.7% being MRSA [25]. In intensive care unit of a Nigerian hospital, 
out of 71 patients with healthcare-associated infection, bloodstream and urinary tract infec-
tions were the commonest infections, and S. aureus was the commonest cause of bloodstream 
infection with 80% of the S. aureus being MRSA [26]. In surgical site infections for 103 patients 
with orthopedic surgery in a hospital in Port Harcourt, Nigeria, the commonest pathogen was 
S. aureus (34%) including 15 patients with MRSA [27]. and prevalence of MRSA with mecA 
gene as 42.3% from 156 S. aureus in clinical isolates from South Western Nigeria with domina-
tion of SCCmec II and SCCmec V [28].
A significant decline in antibiotic resistance was observed in Northeastern Nigeria in contrast 
to the worldwide trend of increasing resistance rates as stated in a study involving changes in 
population structure of S. aureus isolates in 2007 and 2012 from Northeastern Nigeria with a 
reduction in resistance to erythromycin, penicillin, clindamycin and gentamicin in 2012 with 
a decrease of MRSA [29]. The authors have confirmed low to moderate prevalence of MRSA 
in Nigeria in various studies. Ayeni et al. [30] reported 0.5% MRSA prevalence in nares of 
healthy adults. In another of our study by Ayeni et al. [31] where prevalence of MRSA in sam-
ples analyzed in Medical Microbiology Unit of University College Hospital, Ibadan between 
May and October 2012 was done. A 50 S. aureus strains were obtained with 34% of the studied 
S. aureus strains being phenotypically identified as MRSA strain.
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3. Diagnosis of staphylococci infections
Identification of staphylococci is supposed to be a simple straightforward procedure that 
involves culturing of clinical specimens or pure bacterial strains on Columbia agar, mannitol 
salt agar (MSA) or tryptic soy blood agar. If pure biochemical identification is to be used, then 
Gram-positive, nonmotile, non-spore-forming, facultative anaerobic cocci occurring mainly 
in clusters and catalase-positive strains are selected for further tests. Coagulase test will dis-
tinguish between S. aureus and coagulase-negative staphylococci in clinical specimens. There 
is a current interest in small colony variant (SCV) of staphylococci which are nonhemolytic, 
nonpigmented and characterized by pinpoint colonies about 10% of the size of the normal 
colonies [32]. The SCV of S. aureus can contribute to persistent infection and they are associ-
ated with increased antibiotic resistance.
3.1. Overview of different staphylococci identification methods
Rapid latex and hemagglutination assays allows presumptive identification of S. aureus 
based on the detection of clumping factor, capsule types 5 and 8, protein A. They have 
high sensitivity (98–100%) and lower specificity (72–99%) which may be as a result of 
false-positive reactions occurring with some CoNS strains [6]. Novobiocin resistance is 
routinely used to distinguish the intrinsically resistant S. saprophyticus subsp. saprophyti-
cus from other CoNS, e.g. S. epidermidis group. Tube coagulase test with horse plasma has 
been stated as a very accurate method to differentiate between S. aureus and CoNS. It has 
a high specificity [30].
There are commercial and automated systems for identification of staphylococci, e.g. 
Staphylococcus-specialized API Staph, Vitek 2, Rapidec Staph and ID32 Staph strips (bioMéri-
eux) system, BBL Phoenix automated microbiology system, Crystal identification system’s Rapid 
Gram-Positive ID kit (BD, MD), Pos ID Panel family (Siemens, Deerfield, IL), Sherlock microbial 
identification system (MIDI, Newark, DE) and the Biolog systems (Biolog, Hayward, CA) [6].
There are also several molecular approaches for identification of staphylococci. Conserved 
regions with species-specific sequences of universally occurring genes are amplified, for dif-
ferentiation at the species level, e.g. 16S and 23S rRNA, gap, gyrA, sodA, rpoB and tuf genes. 
Sequencing of 16S rRNA gene has wide application in identification of bacterial species. 
However, other genes have been observed to be superior to 16S gene for identification of 
staphylococci. In a previous study, the author had also confirmed previous knowledge that 
sequencing of tuf gene has more discriminatory power in identification of staphylococci 
than partial sequencing of 16S rRNA gene [33]. Also, partial sequencing of rpoB gene has 
better identification power than partial 16S rRNA gene sequencing for the differentiation of 
Staphylococcus subspecies [34].
SCV strains grow on blood agar as pinpoint colonies and they are often nonreactive in nor-
mal biochemical tests because their laboratory detection could be affected by their altered 
metabolism and long generation time. Therefore, molecular methods, such as amplification 
of species-specific DNA targets or 16S rRNA partial sequencing, become the method of choice 
for their identification [35].
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Microarray-based diagnostics test may combine identification of staphylococci with detec-
tion of virulence factors and drug resistance in strains. In positive blood culture smears, a 
nucleic acid hybridization assay (S. aureus/CNS PNA FISH; AdvanDx) targeting rRNA gene 
sequences with the principle of nucleic acid fluorescence in situ hybridization (PNA FISH) 
can be used for rapid identification of S. aureus [6]. Furthermore, spectroscopic and spectro-
metric methods, e.g. Fourier transform infrared (FTIR), Raman spectroscopy and MALDI-
TOF MS are currently used in diagnostic laboratories. MALDI TOF has become a universal 
quick and accurate method for identification of microorganisms including staphylococci, and 
the principle is based on spectra obtained by molecular weight for individual fragments.
Identification of MRSA is primarily by cefoxitin disk screen test, the latex agglutination test 
for PBP2a or selective chromogenic agars [30]. Commercial tests are also available for identifi-
cation of MRSA with combined detection of mecA and toxin genes. By using a multiplex PCR 
approach, mecA and femA can be simultaneously detected for rapid identification of MRSA 
and to differentiate S. aureus (femA1) from CoNS especially in blood samples [36]. An excellent 
correlation was reported between the broth microdilution assay and detection of antibiotic 
resistance genes by multiplex PCR [37].
In some institutions, there is active surveillance that uses rapid laboratory techniques to evaluate 
nasal swab specimens and routinely screen admitted patients, e.g. high-risk patients, patients 
with previous MRSA infection, vascular, orthopedic, or cardiac surgery patients for MRSA.
3.2. Wrong identification of staphylococci
Due to lack of adequate resources, wrong identification of S. aureus which could lead to wrong 
diagnosis of S. aureus infections has been observed. Mannitol salt agar (MSA) is often used in 
many laboratories in some developing countries, e.g. Nigeria for identification of S. aureus. The 
initial design of the agar was with the claim that it supports the growth of coagulase positive 
staphylococci only by being a selective and differential medium: The composition is 7.5% sodium 
chloride, mannitol as the carbohydrate and phenol red. It was claimed that colonies of CoNS and 
other salt-tolerant organisms will produce pink or red colonies, while S. aureus will grow on MSA 
as yellow colonies [38]. However, there are several evidences to disprove this claim.
One hundred and eight-five isolates that had been previously isolated from the nares of col-
lege students’ volunteers in Southern Nigeria were identified by various methods. Growth on 
MSA and slide coagulase tests was highly inaccurate for identification of S. aureus although 
it is an indication of staphylococci; however, this should be taken with caution because other 
organisms like Brevibacterium can also grow on MSA with yellow colonies [30, 39]. The study 
confirmed that tube coagulase test with horse plasma, MALDI TOF mass spectrometry and 
PCR amplification of the spa gene are accurate diagnostic methods for identification of S. 
aureus. Also chromogenic medium, chromIDTM MRSA plate (bioMérieux, France) and Slidex 
MRSA Detection Kit (bioMérieux, France) were accurate for detection of MRSA [30].
In another study by Ayeni and Odumosu [40], it was noted that some organisms are being 
wrongly identified as S. aureus in phenotypic identifications. The study evaluated inaccu-
rate identification of other organisms as S. aureus by collecting 507 phenotypically  identified 
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S. aureus strains (identified by Gram staining, characteristic growth and fermentation on man-
nitol salt agar and blood agar and coagulase formation) obtained from 8 states in Southern 
Nigeria. Standard identification of the isolates was done in the study by sequencing of 16S 
rRNA gene and detection of spa gene. Fifty-four (11%) of the total isolates were confirmed 
as S. aureus, while the rest were CoNS with 85% misidentification, Bacillus sp. with 12% 
misidentification and Brevibacterium sp. with 3% misidentification. The study reported an 
alarming rate of false positive identification of S. aureus which could have resultant effect of 
misdiagnosis and subsequent wrong antibiotic prescription especially in emergency situa-
tion. Therefore, we demonstrated that CoNS grows and ferments mannitol on MSA. Standard 
methods should be used for identification of S. aureus.
We also studied 171 strains of CoNS which have been previously identified as S. aureus as 
a result of growth on MSA. The strains were collected from different locations in Nigeria, 
and ViTEK 2, MALDI-TOF MS and partial sequencing of 16S rRNA gene sequencing (gold 
standard) were used for identification. It was discovered that all strains (13 species of CoNS) 
grow on MSA and ferment mannitol. All tested strains of S. warneri, S. epidermidis, S. pas-
teuri, S. sciuri, S. nepalensis, S. xylosus, S. capitis and S. haemolyticus were correctly identified 
by MALDI-TOF, while all strains of S. gallinarum and S. kloosii were misidentified by MALDI 
TOF with total absence of S. gallinarum in the MALDI-TOF database at the period of this 
study. All tested strains of S. warneri, S. epidermidis, S. xylosus S. gallinarum, S. sciuri, S. capitis 
and S. haemolyticus were correctly identified by ViTEK, while the equipment misidentified 
S. pasteuri and S. nepalensis. It was concluded that growth on MSA for S. aureus is the same 
with CoNS and therefore the growth media cannot differentiate between CoNS and S. aureus. 
ViTEK seems more accurate than MALDI-TOF in identification of CoNS [33].
4. Susceptibility of staphylococci to antibiotics
As a basic principle, empiric use of antimicrobials should be guided by local epidemiology 
and antimicrobial susceptibility pattern as well as the clinical state of the patient, with final 
therapy determined by culture and sensitivity data. Vancomycin is the drug of choice for the 
treatment of MRSA infections, while clindamycin is the commonly used antimicrobial for 
CA-MRSA infections. However, many strains are emerging with reduced susceptibility to 
vancomycin for S. aureus and CoNS strains. MRSA are resistant to penicillin but susceptible 
to penicillinase-stable penicillins, such as methicillin and oxacillin. Healthcare-associated 
MRSAs are multiple resistant to other commonly used antimicrobial agents, including flu-
oroquinolones, erythromycin, tetracycline and clindamycin, while community-associated 
MRSAs are often resistant only to β-lactam agents and sometimes erythromycin and fluoro-
quinolones. In a study, 80% resistance to ampicillin was observed in CoNS, while resistance 
to cefoxitin and ceftriaxone was observed in 58% of the isolates [5].
In an antibiotic susceptibility study, 75.9% sensitivity to rifampicin, 100% sensitivity to van-
comycin and linezolid was reported in catheter-related bloodstream infections in 58 (20 
S. aureus and 38 CoNS) staphylococci in an Egyptian tertiary hospital with the  recommendation 
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that linezolid and rifampicin could be used effectively against MRSA isolated from catheter-
related bloodstream infections [41].
In another study on molecular epidemiology of trimethoprim resistance in 598 human 
S. aureus isolates collected in different locations across sub-Saharan Africa [Gabon, Nigeria 
(two), Namibia and Tanzania] [42]. About 54% of strains were observed to be resistant to tri-
methoprim and the resistance mostly mediated by dfrG gene, which is widespread in Africa. 
The study discourages the use of the drug for the treatment of SSTI caused by CA-MRSA.
Susceptibility of S. aureus strains to linezolid, rifampicin, teicoplanin, vancomycin, mupiro-
cin phosphomycin, fusidic acid, daptomycin and tigecycline with 55 and 72% resistance to 
tetracycline and trimethoprim/sulphamethoxazole, respectively, has been reported, while in 
another study involving S. aureus isolates obtained from infection and asymptomatic carriers 
in Lagos and Ogun States, Nigeria, higher resistance was observed for aminoglycosides in 
clinical isolates, and more prevalent resistances to quinolones and tetracycline were observed 
in carrier isolates [37, 43].
Daptomycin and quinupristin/dalfopristin have been proposed as an alternative to glyco-
peptides in the treatment of MRSA infections, while the use of telithromycin is discouraged 
[44]. Also, all MRSAs were sensitive to amikacin, ciprofloxacin and chloramphenicol, while 
all methicillin-sensitive S. aureus were sensitive to ampicillin/sulbactam in a study [25], while 
fusidic acid resistance was reported in 93.7% of isolates, from prevalence of nasal and pha-
ryngeal carriage of MRSA among inpatients and healthcare workers in an healthcare center 
in Serbia [9].
Osteomyelitis occurs more frequently in children, causing pains, chills and fever. Osteomyelitis 
regularly involves prolonged systemic antibiotic use, and dalbavancin, linezolid and vanco-
mycin were active against staphylococci implicated in bone and joint infections [45].
All S. aureus strains in otitis media case in a developing country were sensitive to gentamycin 
[21], while ciprofloxacin was stated as the most effective antibiotic for treatment of bacterial 
chronic suppurative otitis media [20]. In a study on the prevalence and antimicrobial sus-
ceptibility pattern of external ocular bacterial infections in Ethiopia, the prevalence of MRSA 
infection was 24%, and multidrug resistance was observed in 87% of the isolated bacteria [46].
Ayeni et al. [30] reported susceptible to fusidic acid, rifampicin clindamycin, vancomycin 
and linezolid, with observed high resistance to penicillin and trimethoprim in 185 staphy-
lococci, which had been previously isolated from the nares of college students’ volunteers 
in Southern Nigeria. In another study by Ayeni et al. [31] where the current resistant pat-
tern of S. aureus to β lactam antibiotics in samples analyzed in Medical Microbiology Unit of 
University College Hospital, Ibadan between May and October 2012 were evaluated. A 50 S. 
aureus strains were obtained which were highly resistant to erythromycin (72%), clindamycin 
(78%), aztreonam (70%) and amoxycillin (92%), but highly susceptible to imipenem (90%). 
Variable resistance was observed to cefotaxime (62%), ceftazidine (50%), cefoxitin (66%), cef-
triazone (52%) and amoxycillin/clavulanic acid (50%). All the isolates resistant to amoxicillin/
clavulanic were, however, susceptible to ≥1 of the cephalosporins. All phenotypic identified 
MRSAs were resistant to amoxicillin, erythromycin, clindamycin amoxicillin/clavulanic acid 
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and ≥1 cephalosporin (except 1). About 88% of the studied MRSA strains were sensitive to 
imipenem. S. aureus strains (42%) susceptible to amoxicillin/clavulanic acid were resistant 
to amoxicillin. A synergy was observed between imipenem and aztreonam in some isolates 
which were resistant to aztreonam but sensitive to imipenem which may be an indication that 
combined therapy of imipenem and aztreonam may result in enhanced antimicrobial activity 
of aztreonam. We concluded that cephalosporins are still relatively effective for treatment of 
S. aureus infections due to in vitro evidence.
Another study in our group determined antimicrobial resistance of staphylococci isolated 
from urogenital tracts of humans with a presumptive diagnosis of urinary tract infection in 
45 urogenital samples (endocervical swab, high vaginal swab and urine) from outpatients at 
Igbinedion University Teaching Hospital between April and May 2010. Ten isolates (22% of 
the total samples) of staphylococci were obtained. All the isolates were multidrug resistant 
with exhibited resistance to ≥5 antimicrobials and 100% resistance to ciprofloxacin, nitrofu-
rantoin, augmentin, ampicillin and ceftriazone. All CoNS strains were susceptible to doxycy-
cline, while S. aureus strains were relatively susceptible to TMP/SMX [47].
Ceftobiprole and ceftaroline are new cephalosporins active against S. aureus, including MRSA 
strains causing infections like pneumonia and staphylococci soft tissue infections in adults. 
They have been recently approved in Europe (Ceftobiprole by the European Medicines 
Agency) and the USA (Ceftaroline by U.S. Food and Drug Administration) for treatment of 
S. aureus and MRSA infections. However, resistance to these antibiotics is emerging, and it is 
often associated with mutations in mecA, increasing in the production of PBP4, which medi-
ates resistance to ceftobiprole and ceftaroline [48]. However, a global surveillance conducted 
prior to the European launch of ceftaroline revealed 4 S. aureus from 8037 tested strains with 
ceftaroline resistance [49]. In another study on ceftaroline against 1971 S. aureus isolates col-
lected from seven countries in the Asia-Pacific region in 2012 [50], there was ceftaroline sus-
ceptibility rate of 86.9%, and surprisingly in Thailand, more than half (52.8%) of isolates were 
resistant to ceftaroline. Minimal resistance to ceftobiprole has been reported by Hodille et al. 
[51] (1 of 440 S. aureus) strains isolated from bronchopulmonary infections being resistant to 
ceftobiprole, while another study involving MRSA isolates from colonization (n  =  37) and 
infection (n  =  23) isolated from Côte d’Ivoire, Congo, Gabon and Nigeria, 16.7 and 15% of 
strains were resistant to ceftaroline and ceftobiprole, respectively, and surprisingly detected 
only in Nigeria [52].
4.1. Susceptibility of staphylococci to non-antibiotic substances
Other natural and beneficial bacteria have been found to be effective against staphylococci 
in vitro. This has been demonstrated in previous studies. The first discussion is on medicinal 
plants that have been proven over many generations to be effective against several infectious 
diseases. The plants from the genus Combretum have been shown to be part of recipe for 
the traditional treatment of various diseases with broad antimicrobial spectrum of 36 spe-
cies of the genus having antimicrobial activities [53, 54]. In our study involving the antibac-
terial activities of the methanol extracts from the leaves of Combretum hispidum, Combretum 
racemosum and Combretum platypterum against seven strains of MRSA in vitro, extract from 
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Combretum racemosum leaves had high anti-MRSA activities (0.16–1.25 mg/mL MIC values) on 
all tested strains of MRSA [55]. This could be a potential source of newer antimicrobial agent 
against MRSA infections.
Lactic acid bacteria (LAB) are beneficial bacteria with good antimicrobial activi-
ties against many pathogenic bacteria. We reported good inhibition of growth of 
uropathogenic S. saprophyticus and S. aureus by L. fermentum, L. brevis, L. plantarum, 
Streptococcus durans and Lactococcus lactis [56]. In another study in our group, LAB 
from salad vegetables have anti-MRSA abilities in vitro against five confirmed MRSA 
strains. P. pentosaceus and L. cellobiosus exhibited widest zones of inhibition. In the 
agar overlay, P. pentosaceus and W. confusa showed the widest zones of 28 and 24 mm, 
respectively [57].
In a recently published co-culture study that we did with LAB and MRSA, the cell free 
supernatant of L. fermentum and L. plantarum was generally active against MRSA, the largest 
zone of inhibition was 13 mm with L. plantarum. Further experiment of co-culture was done 
in the study with MRSA and L. plantarum 9, L. buchneri SM04, L. fermentum 008, L. brevis 
21 and Weissella paramesenteroides. All the tested LAB reduce the viable counts of MRSA 
from 10 log to 3 log after 24 h of co-incubation, while L. plantarum 9 and L. fermentum 008 
totally inhibited the growth of MRSA after 72 h of co-culture and the MRSA could not 
grow in overnight culture of LAB, after 24 h of incubation [58]. In another study from our 
group, LAB strains were assayed for antimicrobial ability against two uropathogenic S. 
aureus strains. The selected Staphylococcus spp. was generally resistant to macrolides (100% 
resistance to clarithromycin), aminoglycosides (50–90%), fosfomycin and rifampicin (20%), 
while 70% resistance was observed in co-trimoxazole. Lesser resistance was observed in the 
quinolones (10–20%), and β lactams antibiotics have variable resistance (30–90%). However, 
22 LAB strains had strong suppression of target S. aureus strains with clear zones (>10 mm) 
around the streaks [59].
5. Conclusion
Staphylococci are implicated in various infectious states in different parts of the world with 
high prevalence. However, characteristics growth on mannitol salt agar is insufficient to dif-
ferentiate between S. aureus and coagulase-negative staphylococci. Other standard identifica-
tion methods should be used. Staphylococci antibiotic susceptibility varies between different 
locations and site of infection.
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